Yousif Capital Management LLC Lowers Stock Position in Danaher Co. (NYSE:DHR)

Yousif Capital Management LLC lowered its position in Danaher Co. (NYSE:DHR) by 4.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 73,845 shares of the conglomerate’s stock after selling 3,323 shares during the period. Yousif Capital Management LLC’s holdings in Danaher were worth $16,951,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Wedge Capital Management L L P NC raised its holdings in shares of Danaher by 3.2% in the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 38 shares during the last quarter. Meridian Financial Partners LLC raised its holdings in shares of Danaher by 4.4% in the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock valued at $266,000 after purchasing an additional 40 shares during the last quarter. Kovack Advisors Inc. grew its position in Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock valued at $346,000 after buying an additional 41 shares during the period. Well Done LLC raised its position in Danaher by 1.2% in the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock worth $987,000 after acquiring an additional 42 shares during the period. Finally, Waypoint Capital Advisors LLC raised its position in Danaher by 0.9% in the third quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after acquiring an additional 42 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. JPMorgan Chase & Co. lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Barclays lowered their price objective on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Stifel Nicolaus lifted their price objective on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research report on Wednesday, October 23rd. Scotiabank assumed coverage on shares of Danaher in a research report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective on the stock. Finally, Raymond James reiterated a “market perform” rating on shares of Danaher in a research note on Monday. Seven research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Trading Up 0.4 %

Shares of Danaher stock opened at $215.05 on Wednesday. Danaher Co. has a 1 year low of $210.04 and a 1 year high of $281.70. The firm has a market cap of $155.33 billion, a PE ratio of 40.73, a PEG ratio of 2.80 and a beta of 0.83. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The company has a 50 day simple moving average of $234.93 and a two-hundred day simple moving average of $252.88.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm earned $2.09 earnings per share. Analysts expect that Danaher Co. will post 7.77 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, January 31st. Shareholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.50%. Danaher’s payout ratio is presently 20.45%.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 10.90% of the stock is currently owned by company insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.